Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1982-11-15
1984-10-02
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
536 74, A61K 3171, C07H 1708
Patent
active
044747683
ABSTRACT:
Antibacterial N-methyl 11-aza-10-deoxo-10-dihydroerythromycin A and pharmaceutically acceptable acid addition salts thereof, intermediates therefor, and processes for their preparation.
REFERENCES:
patent: 3928387 (1975-12-01), Kierstead et al.
patent: 4110531 (1978-08-01), Sciavolino
patent: 4283527 (1981-08-01), Sciavolino
patent: 4328334 (1982-05-01), Kobrehel et al.
Migridichian Organic Synthesis, vol. 1, New York: Reinhold Pub. Corp. 1957, p. 476.
Greene, "Protective Groups in Organic Synthesis", John Wiley & Sons, Inc., N.Y., 1981, p. 281.
Brown Johnnie R.
Frost Albert E.
Knuth Charles J.
Peselev Elli
Pfizer Inc.
LandOfFree
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-526429